Original language | English (US) |
---|---|
Pages (from-to) | 1205-1208 |
Number of pages | 4 |
Journal | Clinical Infectious Diseases |
Volume | 55 |
Issue number | 9 |
DOIs |
|
State | Published - Nov 1 2012 |
Funding
ceived grant support from F. Hoffmann–La Roche for principal investigator–initiated clinical influenza research, paid to the Chinese University of Hong Kong; an honorarium for consultancy work for GlaxoSmithKline; and conference support from Sanofi-Aventis Hong Kong, MSD (Asia) and Pfizer Hong Kong, paid to the Chinese University of Hong Kong. M. G. I. has received research support, paid to Northwestern University Feinberg School of Medicine, from BioCryst, Cellex, Genentech/Roche, and Glaxo-SmithKline. He is a paid member of a data and safety monitoring board for NexBio and has provided remunerated consultation to Abbott, Crucell, and Genentech/Roche; he has also provided unremunerated consultation to Adamas, Alios, BioCryst, Biota, Cellex, Clarassance, Glaxo-SmithKline, MediVector/Toyama, TheraClone, and Visterra.
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases